These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 28903413)

  • 41. Evaluating the performance of clinical criteria for predicting mismatch repair gene mutations in Lynch syndrome: a comprehensive analysis of 3,671 families.
    Steinke V; Holzapfel S; Loeffler M; Holinski-Feder E; Morak M; Schackert HK; Görgens H; Pox C; Royer-Pokora B; von Knebel-Doeberitz M; Büttner R; Propping P; Engel C;
    Int J Cancer; 2014 Jul; 135(1):69-77. PubMed ID: 24493211
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prognostic impact of mismatch repair genes germline defects in colorectal cancer patients: are all mutations equal?
    Maccaroni E; Bracci R; Giampieri R; Bianchi F; Belvederesi L; Brugiati C; Pagliaretta S; Del Prete M; Scartozzi M; Cascinu S
    Oncotarget; 2015 Nov; 6(36):38737-48. PubMed ID: 26485756
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hereditary nonpolyposis colorectal cancer: diagnostic strategies and their implications.
    Bonis PA; Trikalinos TA; Chung M; Chew P; Ip S; DeVine DA; Lau J
    Evid Rep Technol Assess (Full Rep); 2007 May; (150):1-180. PubMed ID: 17764220
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular characterization of the spectrum of genomic deletions in the mismatch repair genes MSH2, MLH1, MSH6, and PMS2 responsible for hereditary nonpolyposis colorectal cancer (HNPCC).
    van der Klift H; Wijnen J; Wagner A; Verkuilen P; Tops C; Otway R; Kohonen-Corish M; Vasen H; Oliani C; Barana D; Moller P; Delozier-Blanchet C; Hutter P; Foulkes W; Lynch H; Burn J; Möslein G; Fodde R
    Genes Chromosomes Cancer; 2005 Oct; 44(2):123-38. PubMed ID: 15942939
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Risk of secondary malignancy (including breast) in patients with mismatch-repair protein deficiency.
    Clay MR; Allison KH; Folkins AK; Longacre TA
    Am J Surg Pathol; 2014 Nov; 38(11):1494-500. PubMed ID: 24921635
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical and Molecular Assessment of Patients with Lynch Syndrome and Sarcomas Underpinning the Association with
    de Angelis de Carvalho N; Niitsuma BN; Kozak VN; Costa FD; de Macedo MP; Kupper BEC; Silva MLG; Formiga MN; Volc SM; Aguiar Junior S; Palmero EI; Casali-da-Rocha JC; Carraro DM; Torrezan GT
    Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32659967
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pancreatic cancer 'mismatch' in Lynch syndrome.
    Hendifar AE; Larson BK; Rojansky R; Guan M; Gong J; Placencio V; Tuli R; Hitchins M
    BMJ Open Gastroenterol; 2019; 6(1):e000274. PubMed ID: 31275582
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evidence for presence of mismatch repair gene expression positive Lynch syndrome cases in India.
    Bashyam MD; Kotapalli V; Raman R; Chaudhary AK; Yadav BK; Gowrishankar S; Uppin SG; Kongara R; Sastry RA; Vamsy M; Patnaik S; Rao S; Dsouza S; Desai D; Tester A
    Mol Carcinog; 2015 Dec; 54(12):1807-14. PubMed ID: 25420488
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Spectrum of MLH1 and MSH2 mutations in Chilean families with suspected Lynch syndrome.
    Alvarez K; Hurtado C; Hevia MA; Wielandt AM; de la Fuente M; Church J; Carvallo P; López-Köstner F
    Dis Colon Rectum; 2010 Apr; 53(4):450-9. PubMed ID: 20305446
    [TBL] [Abstract][Full Text] [Related]  

  • 50. TumorNext-Lynch-MMR: a comprehensive next generation sequencing assay for the detection of germline and somatic mutations in genes associated with mismatch repair deficiency and Lynch syndrome.
    Gray PN; Tsai P; Chen D; Wu S; Hoo J; Mu W; Li B; Vuong H; Lu HM; Batth N; Willett S; Uyeda L; Shah S; Gau CL; Umali M; Espenschied C; Janicek M; Brown S; Margileth D; Dobrea L; Wagman L; Rana H; Hall MJ; Ross T; Terdiman J; Cullinane C; Ries S; Totten E; Elliott AM
    Oncotarget; 2018 Apr; 9(29):20304-20322. PubMed ID: 29755653
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lynch syndrome in the 21st century: clinical perspectives.
    Tiwari AK; Roy HK; Lynch HT
    QJM; 2016 Mar; 109(3):151-8. PubMed ID: 26224055
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lower incidence of colorectal cancer and later age of disease onset in 27 families with pathogenic MSH6 germline mutations compared with families with MLH1 or MSH2 mutations: the German Hereditary Nonpolyposis Colorectal Cancer Consortium.
    Plaschke J; Engel C; Krüger S; Holinski-Feder E; Pagenstecher C; Mangold E; Moeslein G; Schulmann K; Gebert J; von Knebel Doeberitz M; Rüschoff J; Loeffler M; Schackert HK
    J Clin Oncol; 2004 Nov; 22(22):4486-94. PubMed ID: 15483016
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A Hereditable Mutation of MSH2 Gene Associated with Lynch Syndrome in a Five Generation Chinese Family.
    Shao WH; Wang CY; Wang LY; Xiao F; Xiao DS; Yang H; Long XY; Zhang L; Luo HG; Yin JY; Wu W
    Cancer Manag Res; 2020; 12():1469-1482. PubMed ID: 32161499
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Microsatellite instability: an update.
    Yamamoto H; Imai K
    Arch Toxicol; 2015 Jun; 89(6):899-921. PubMed ID: 25701956
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of Lynch syndrome-associated DNA mismatch repair-deficient bladder cancer in a Japanese hospital-based population.
    Kagawa M; Kawakami S; Yamamoto A; Suzuki O; Kamae N; Eguchi H; Okazaki Y; Yamamoto G; Akagi K; Tamaru JI; Yamaguchi T; Arai T; Ishida H
    Int J Clin Oncol; 2021 Aug; 26(8):1524-1532. PubMed ID: 34213665
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinicopathological features and management of cancers in lynch syndrome.
    Aarnio M
    Patholog Res Int; 2012; 2012():350309. PubMed ID: 22619739
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Assessing how reduced expression levels of the mismatch repair genes MLH1, MSH2, and MSH6 affect repair efficiency.
    Kansikas M; Kasela M; Kantelinen J; Nyström M
    Hum Mutat; 2014 Sep; 35(9):1123-7. PubMed ID: 24924810
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lynch Syndrome/Hereditary Non-polyposis Colorectal Cancer (HNPCC).
    Stoffel EM
    Minerva Gastroenterol Dietol; 2010 Mar; 56(1):45-53. PubMed ID: 20190724
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Characterization of a rare variant (c.2635-2A>G) of the MSH2 gene in a family with Lynch syndrome.
    Cariola F; Disciglio V; Valentini AM; Lotesoriere C; Fasano C; Forte G; Russo L; Di Carlo A; Guglielmi F; Manghisi A; Lolli I; Caruso ML; Simone C
    Int J Biol Markers; 2018 Apr; ():1724600818766496. PubMed ID: 29690800
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The MSH2 c.793-1G>A variant disrupts normal splicing and is associated with Lynch syndrome.
    Li Y; Yu L; Cui J; Yin J; Wu W
    Front Oncol; 2023; 13():1131011. PubMed ID: 37538120
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.